Navigation Links
NUCRYST Approves $0.80 Per Share Cash Distribution to Shareholders
Date:2/12/2009

ephew; and management's response to these factors. Although we have attempted to identify the important risks, uncertainties and other factors that could cause actual results or events to differ materially from those expressed or implied in the forward-looking statements in this release, there may be other factors that cause actual results or events to differ from those expressed or implied in forward looking statements. For a more thorough discussion of the risks associated with our business, see the "Risk Factors" section in our Annual Report on Form 10-K for the year ended December 31, 2007 and in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2008, filed with the U.S. Securities and Exchange Commission on EDGAR at www.sec.gov and with securities authorities in Canada on SEDAR at www.sedar.com. All forward-looking statements are expressly qualified in their entirety by this cautionary statement and NUCRYST disclaims any intention or obligation to revise or update any forward-looking statements whether as a result of new information, future developments or otherwise after the date hereof.


'/>"/>
SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. NUCRYST and Smith & Nephew Revise Agreements
2. Webcast Advisory - NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Third Quarter Results
3. NUCRYST Pharmaceuticals announces 2007 third quarter results
4. NUCRYST Pharmaceuticals announces year-end results
5. NUCRYST Announces Senior Management Change
6. NUCRYST Announces Management Realignment and R&D Portfolio Change
7. NUCRYST Announces First Quarter 2008 Financial Results
8. NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer
9. NUCRYST Pharmaceuticals to Release Second Quarter 2008 Financial Results on Tuesday, August 12, 2008
10. NUCRYST Receives Deficiency Notice from NASDAQ
11. The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 Liberty University has received accreditation for ... from the Council for Accreditation of Counseling & Related ... Center for Counseling & Family Studies , is under ... university’s new School of Behavioral Sciences. Prior to the formation ...
(Date:1/22/2015)... TN (PRWEB) January 22, 2015 Gabe’s Chemo Duck ... Duck App, the first app ever created for kids with cancer. ... Apple phones and devices, is filled with enjoyable games to help ... and treatments. The free app helps to keep kids entertained, educated ...
(Date:1/22/2015)... is a famous wedding dress company offering many trendy designs. ... Facebook, Twitter, and Pinterest. The fans will have an opportunity ... every week. , Moreover, the company has extended its 2015 ... homepage for more information. , Angelweddingdress is a ...
(Date:1/22/2015)... January 22, 2015 Juvent Sports ( ... the 2015 PGA Merchandise Show to bestow a Juvent ... female amateur golfer, Arlene McKitrick. The award commemorated and ... golf tournament win. She won her first amateur tournament ...
(Date:1/22/2015)... over 20 years, Dr. David Cruz of Cruz Chiropractic Care ... just about every type of injury that can result from car ... twenty-plus years, the team at Doctors on Liens has ... doctor. With the combined breadth of experience between the ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2
... Inc., a leading,global provider of enterprise Business Process ... solutions, announced,today that it will partner with DOKUMENTA ... Code (EPC Gen. 2) RFID solution, to help,suppliers ... Initiative. The Future Store Initiative is aimed ...
... The Governing Board,of Texas Medical Liability Trust ... for TMLT policyholders. The Board has,approved a 6.5% ... January 1, 2008. In addition, all current TMLT ... dividend equal to 22% of,their expiring premium. The ...
... Medical Services,International Inc. (Pink Sheets: MSITF) wishes to ... distributors indicate that it,will produce 1.24 million test kits ... of the fiscal year. The majority of the kits ... also deliver VScan TB,Malaria, Hepatitis C and Dengue Fever ...
... In Use of Anticonvulsants, Especially When Prescribed,Off-Label, ... in treating bipolar disorder, fibromyalgia, and various,kinds of ... always the best,initial choice to treat those conditions ... to the latest report from Consumer Reports Best ...
... Key Time to Start Talking With ,Tweens,: TimeToTalk.org, Provides Parents With Helpful ... ... -, NEW YORK, Sept. 5 ... drugs and alcohol, The Partnership for a,Drug-Free America(R),s new nationwide parent movement ...
... 2007 Inc. 5,000, No. 58 in the ... 97.2%, PORTLAND, Ore., Sept. 5 Inc. magazine has ... on,its first-ever Inc. 5,000 list of the fastest-growing private companies ... annual Inc.,500 list, catches many businesses that are too big ...
Cached Medicine News:Health News:Shipcom Partners With DOKUMENTA for METRO's Future Store Initiative 2Health News:Shipcom Partners With DOKUMENTA for METRO's Future Store Initiative 3Health News:Texas' Largest Physician Carrier Announces 5th Successive Rate Cut on Anniversary of Lawsuit Reform 2Health News:Consumer Reports' Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best 2Health News:Consumer Reports' Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best 3Health News:Middle School Marks Most Critical Time to Start Ongoing Conversations About Drug and Alcohol Use With Kids 2Health News:Middle School Marks Most Critical Time to Start Ongoing Conversations About Drug and Alcohol Use With Kids 3Health News:Middle School Marks Most Critical Time to Start Ongoing Conversations About Drug and Alcohol Use With Kids 4Health News:First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion 2Health News:First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion 3Health News:First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion 4
(Date:1/23/2015)... Jan. 23, 2015  Mallinckrodt plc (NYSE: MNK ... approved a share repurchase program. The open-ended authorization permits ... Mallinckrodt plc ordinary shares. "Funding additional ... priorities as we continue to pursue a range of ...
(Date:1/23/2015)... January 23, 2015 Heptares Therapeutics, the clinical-stage ... announce that the Malcolm Campbell Memorial Prize for ... President of Chemistry), Fiona Marshall (Chief Scientific Officer ... and co-founder) for the seminal contributions to GPCR drug discovery ...
(Date:1/22/2015)... a privately held medical device company, announced today that ... ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to sell ... cancer in Japan . ViewRay,s technology, ... only MRI-guided radiation therapy system that images and treats ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
... The global cardiovascular device industry is expanding quickly, ... billion by 2015. The boom in ... the world,s growing number of heart health-related diseases: the ... in the world currently suffer from cardiovascular diseases. ...
... (Nasdaq: BIOD ) today announced that Dr. Errol ... at the 6th Annual JMP Securities Healthcare Conference at the ... for Tuesday, September 27, 2011 at 8:30 a.m. ET (5:30 ... replay of the presentation, please visit the Investors section of ...
Cached Medicine Technology:Cardiovascular Device Market Research Update- September 2011 2
... monitoring for flexible care settings., ... combine portability and measurement flexibility to ... of intermediate care environmentsat the patients ... heritage in patient monitoring, IntelliVue has ...
... hospital-grade monitoring capabilities into the growing health ... state management. The system is unique ... range of clinical applications, from continuous real-time ... periodic monitoring of patients outside the hospital, ...
Generra Focus 5 is a basic vital sign monitor. , ,Adult, pediatric, and neonatal. , ,Providing high quality, affordable products for efficiency in patient care....
... The Acuity Central Monitoring Station ... for up to 60 patients from ... interface uses simple point and click ... trackball. The clinician can initiate or ...
Medicine Products: